More recently, it has been demonstrated that 131I-conjugated, anti-HER2 Nbs can be used at low doses, for SPECT imaging, and at higher doses, for targeted radionuclide therapy, to both detect and treat HER2+ tumor mouse models [114]. Here, ERBB2 is linked to neoplasm.